Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

This Award Notice opportunity from Department Of Health And Human Services was posted on November 17, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

VACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASES

Awarded
75N98027D00001Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541715
New
Federal
APEX Arsenal Solutions Marketplace
Solicitation # HQ0034-27-S-CAPX
The APEX Arsenal Solutions Marketplace (AASM) is a long-term open call initiated by the Department of War (DoW) Office of Industrial Base Growth, managed by the Applied Research Institute and supported by the Washington Headquarters Services Acquisition Directorate. This initiative seeks to identify and curate hardware, software, systems, and workforce development solutions that strengthen the defense industrial base and close critical capability gaps for the Warfighter. The program focuses on the development, scaling, and sustainment of emerging technologies and critical materials, making these solutions available for procurement through rapid acquisition pathways. The submission window runs from December 1, 2026, through November 30, 2027, with submissions collected in monthly cycles. Applicants must submit an unclassified .mp4 video no longer than five minutes and a completed submission form detailing their organization name, Unique Entity Identifier (UEI), and Technology Readiness Level (TRL). Submissions are evaluated by a peer panel of subject matter experts and a Government Selecting Official based on the clarity of the problem description, the strength of the proposed solution, the degree of technological advancement over current capabilities, and the viability of the business model. To maintain integrity, strict organizational conflict of interest protocols are in place, prohibiting assessors from evaluating their own technologies or those in which they hold a financial interest.
Washington Headquarters Services

POSTED

about 14 hours ago

DEADLINE

in about 1 year
NAICS: 541715
New
Federal
Missile Defense Agency - NOBLE Announcement: Machine Aided Software Modernization (MASM)
Solicitation # HQ0860-27-S-C011
The Missile Defense Agency (MDA) is seeking innovative industry solutions for its Next Generation Software Office (NGSW) through the Machine Aided Software Modernization (MASM) solicitation, number HQ0860-27-S-C011. The objective is to drive digital transformation and technology integration within the Missile Defense System, specifically focusing on the development of AI/ML-driven tools for automated code translation and refactoring of legacy code, SI-driven security vulnerability identification and remediation, automated testing and verification of machine-generated code, and seamless DevSecOps integration with DoD and MDA software factories. The effort requires strict compliance with DoD cybersecurity frameworks, including CMMC and NIST SP 800-171, and involves secure interfacing with both classified and unclassified systems. This is a two-step competitive process. Step-one requires the submission of a white paper, a Rough Order of Magnitude cost estimate, and a program summary quad chart by December 17, 2026. White papers are evaluated based on technical achievement, research capabilities, and program management, with a strong emphasis on scientific merit, innovation, and alignment with DoD priorities. Step-two involves negotiations for an award, which may be a FAR-based procurement contract or an Other Transaction (OT) Agreement. Eligible respondents include large and small businesses, non-traditional defense contractors, non-profit organizations, and accredited educational institutions. All offerors must be registered in the System for Award Management (SAM) and must disclose any organizational conflicts of interest or the use of foreign nationals.
Missile Defense Agency (mda)

POSTED

about 14 hours ago

DEADLINE

in 30 days
NAICS: 541715
New
Federal
Altered B Proposers Day
Solicitation # DARPA-SN-27-20
The Altered B Proposers Day, issued by the Defense Advanced Research Projects Agency (DARPA) Defense Sciences Office under solicitation DARPA-SN-27-20, is an informational event designed to introduce the research community to the Altered B program vision. The program seeks foundational breakthroughs in altermagnetism to enable revolutionary low-power electronic and computational capabilities for defense and civilian applications. The effort is divided into two primary focus areas: Materials Synthesis, Processing, and Characterization, which focuses on the discovery and scaling of altermagnetic materials, and Integration and Device Fabrication, which focuses on developing functional hardware demonstrators. Key target prototypes include magnetoresistive RAM (MRAM), high-frequency signal processors, and neuromorphic computing components. This event is not a formal solicitation for proposals or abstracts, and a formal Program Announcement is anticipated for release in December 2026 via sam.gov. The Proposers Day is open to U.S. citizens, permanent residents, and foreign nationals, with specific identity verification and official visit requirements for foreign government officials. Interested parties may submit a single PDF slide for a Lightning Talk by noon on December 2, 2026, provided the content is appropriate for public release. All attendees must present valid government-issued photo identification for physical entry. Technical and administrative inquiries are directed to Program Manager Keith Whitener at [email hidden].
Defense Advanced Research Projects Agcy

POSTED

about 14 hours ago

DEADLINE

in 20 days

AI Contract Overview

Show more

This contract, titled Vaccine (and Other Biologic) Manufacturing Services for Infectious Diseases, was awarded by the National Institutes of Health NIAID under the Department of Health and Human Services. The agreement is structured as an IDIQ contract with a guaranteed minimum award of 10,000 dollars. The services associated with this award fall under NAICS code 541715 and are to be performed in Saskatoon, Saskatchewan, Canada. The primary point of contact for this action is Hamed Hassanzadeh Makou, based out of the agency office in Bethesda, Maryland.

General Info

NIH NIAID IDIQ contract for biologic manufacturing services in Saskatoon, Saskatchewan, Canada.

Contract Value

$48,000,000

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance

Saskatoon, CA-SK, CAN

Set-Aside

NONE

Award Issued Date

Documents

0

No documents available

This contract was awarded without public documents.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

This one is closed. Find the next one like it.

Open contracts like this one, right now:

  • Research and Technical Analysis for Test SystemsOpen now, due in 17 days
  • Altermagnetic Material CharacterizationOpen now, due in 21 days
See open contracts like this

Ask CLEATUS

I've read this contract. Ask me anything.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Niaid
Contacts1 person available
OfficeBETHESDA, MD, 20892, USA

Full Description

Show more

IDIQ Guaranteed Minimum awarded in the amount of $10,000.

More opportunities from Department Of Health And Human Services → National Institutes Of Health Niaid

Same awarding agency

NAICS: 541715
New
Federal
AUTOIMMUNE DISEASES STATISTICAL & CLINICAL COORDINATING CENTER (AD-SCCC)
Solicitation # 75N93026R00009
The National Institute of Allergy and Infectious Diseases (NIAID) within the National Institutes of Health (NIH) is seeking to extend the contract for the Autoimmune Diseases Statistical and Clinical Coordinating Center (AD-SCCC). This project provides essential support for the design, development, execution, and analysis of clinical research focused on autoimmune diseases, mucosal immunology, and primary immune deficiencies. The scope of work includes supporting the Autoimmunity Centers of Excellence and Immune Tolerance Network (ACE) and investigator-initiated clinical trials (IICT). Key responsibilities encompass statistical design and analysis, protocol development, data management, clinical safety and pharmacovigilance support, and the management of biological specimen repositories and collaboration portals. The NIAID intends to negotiate a sole source modification with Rho Federal Systems Division, Inc. under FAR Part 6.302-1 and HHSAR Part 306.302-1 to avoid significant disruptions to critical services and ensure participant safety and data integrity. The proposed 18-month extension is structured as two discrete option periods: a 12-month period from February 1, 2027, through January 31, 2028, and a 6-month period through July 31, 2028. This extension maintains the existing term type/level of effort contract structure and scope to ensure continuity of operations while the agency completes a separate competition process.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

1 day ago

DEADLINE

in 14 days
View Details
NAICS: 541715
New
Federal
2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases
Solicitation # HHS-NIH-NIAID-BAA2026-1
The National Institute of Allergy and Infectious Diseases (NIAID) is soliciting proposals under Broad Agency Announcement HHS-NIH-NIAID-BAA2026-1 to advance medical interventions for infectious diseases. The initiative is divided into three primary research areas: Research Area 001 focuses on developing vaccine candidates using needle-free delivery routes through early-phase clinical trials; Research Area 002 targets the development of safe and effective therapeutic products, such as small molecules or monoclonal antibodies, for serious infectious diseases that are refractory to current treatments; and Research Area 003 seeks innovative in vitro diagnostic technology platforms capable of rapid, automated detection and identification of priority viral pathogens, preferably with a sample-to-answer time of less than two hours. The NIAID estimates up to 16 million dollars in funding for Fiscal Year 2027, utilizing cost-reimbursement completion-type contracts with performance periods of up to five years. Proposals must be submitted electronically via the eCPS portal by December 8, 2026, at 3:00 PM Eastern Time. Awards will be based on technical merit as the paramount consideration, followed by cost realism, with a requirement that proposals be deemed technically acceptable by a peer review group. All submissions must adhere to strict formatting guidelines, including a 75-page limit for technical proposals and compliance with HHS EIT accessibility and Section 508 standards.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

1 day ago

DEADLINE

in 21 days
View Details

Earlier notices in this NAICS code

Posted before this notice, open and closed

Get AI-powered intelligence on the opportunities still open

Every solicitation package arrives shredded into a compliance breakdown and matched to your past performance, with incumbent history and alerts on amendments and award.

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS